U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286682) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants' on Dec. 03.
Brief Summary: The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants
Study Start Date: Dec. 08
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: UCB5285
Participants will receive UCB5285 as prespecified in each cohort.
OTHER: Placebo
Participants will receive matching placebo as prespecified in each cohort.
Recruitment Status: NOT_YET_RECRUITING...